evoke semaglutide AD/PD 2026: Novo Nordisk's fails to demonstrate any benefit for early Alzheimer's Oral semaglutide for Alzheimer's

And there are tons of weight loss secrets out there from a myriad of diets to out-of-this-world supplements

The initiation period is too early for meaningful weight loss assessment, and the novelty effect can create optimistic bias

2024;26(Suppl 4):1627

Age-related changes in activities of mitochondrial electron transport complexes in various tissues of the mouse

December 2, 2025: Zepbound Complication Lawsuits Continue as Eli Lilly Slashes Price Zepbound patients are lodging legal claims against Eli Lilly, alleging the company was untruthful about the risk of pancreatitis, ileus, gastroparesis, and other side effects